Adirondack Trust Company’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.6K Hold
460
0.01% 310
2026
Q1
$45.7K Hold
460
0.02% 259
2025
Q4
$56K Hold
460
0.02% 242
2025
Q3
$51.6K Hold
460
0.02% 251
2025
Q2
$61.6K Hold
460
0.02% 225
2025
Q1
$30.9K Hold
460
0.01% 274
2024
Q4
$28.7K Hold
460
0.01% 282
2024
Q3
$72.2K Hold
460
0.03% 211
2024
Q2
$69.3K Hold
460
0.03% 208
2024
Q1
$34K Hold
460
0.01% 268
2023
Q4
$37.5K Hold
460
0.02% 259
2023
Q3
$25.2K Hold
460
0.01% 266
2023
Q2
$42.9K Hold
460
0.02% 221
2023
Q1
$34.8K Hold
460
0.02% 226
2022
Q4
$28.4K Hold
460
0.01% 240
2022
Q3
$19K Hold
460
0.01% 266
2022
Q2
$14K Hold
460
0.01% 283
2022
Q1
$12K Buy
460
+240
+109% +$4.3K 0.01% 303
2021
Q4
$4K Buy
+220
New +$5.51K ﹤0.01% 377

Other funds holding TMDX

Adirondack Trust Company's TMDX Position: Q2 2026 in Review

Adirondack Trust Company held its Transmedics (TMDX) position steady in Q2 2026 at 460 shares worth $30.6K. The position accounts for 0.01% of the portfolio, ranked #310.

Adirondack Trust Company first reported a position in TMDX in Q4 2021 and has held it in 19 quarters since. The position peaked at $72.2K in Q3 2024. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Adirondack Trust Company held 460 shares of Transmedics worth $30.6K as of Q2 2026.
  • Adirondack Trust Company left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #310 holding.
  • Adirondack Trust Company first reported a position in Transmedics in Q4 2021 and has held it in 19 quarters since.
  • Adirondack Trust Company's Transmedics position peaked at $72.2K in Q3 2024.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.